Aurobindo Pharma Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE406A01037 52Wk High (Rs.) 1420 BV (Rs.) 562.21 FV (Rs.) 1.00
Bookclosure 08/08/2025 52Wk Low (Rs.) 1010 EPS (Rs.) 60.02 P/E (X) 18.37
Mkt Cap. (Rs. Cr.) 64,033.38 P/BV (X) 1.96 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsJun 25Mar 25Dec 24Sep 24Jun 24
Net Sales/Income from operations2822.142721.432883.562757.882460.09
Other Operating Income26.0310.5633.0766.710.00
Total Income From Operations2848.172731.992916.632824.592460.09
      
EXPENDITURE     
Consumption of Raw Materials1340.011360.701506.591424.741318.18
Purchase of Traded Goods14.3816.3119.0616.1613.60
Increase/Decrease in Stocks38.4860.52-61.37-31.25-35.56
Employees Cost282.97273.11265.15265.48259.33
Depreciation70.0293.8868.2868.1666.88
Other Expenses375.99424.84474.05428.58405.61
Total Expenses2121.852229.362271.762171.872028.04
      
P/L Before Other Inc. , Int., Excpt. Items & Tax726.32502.63644.87652.72432.05
Other Income83.77113.9854.26122.6665.32
P/L Before Interest, Excpt. Items & Tax810.09616.61699.13775.38497.37
Interest60.0061.0966.1951.6351.13
P/L Before Exceptional Items & Tax750.09555.52632.94723.75446.24
P/L Before Tax750.09555.52632.94723.75446.24
Tax190.96147.35160.89186.22117.20
P/L After Tax from Ordinary Activities559.13408.17472.05537.53329.04
Net Profit/Loss For the Period559.13408.17472.05537.53329.04
      
Equity Share Capital58.0858.0858.0858.0858.59
EPS Before Extra Ordinary *     
Basic EPS (Rs.)9.637.038.139.215.62
Diluted EPS (Rs.)9.637.038.139.215.62
EPS After Extra Ordinary *     
Basic EPS (Rs.) 9.637.038.139.215.62
Diluted EPS (Rs.) 9.637.038.139.215.62
      
PBITOE Margin (%)25.5018.3922.1123.1017.56
PBTE Margin (%)26.3320.3321.7025.6218.13
PBT Margin (%)26.3320.3321.7025.6218.13
PAT Margin (%)19.6314.9416.1819.0313.37